TNF and ovarian cancer: A retrospective analysis of patients undergoing radical ovarian cancer surgery revealed that, compared to the Midazolam group, the DEX group had stable hemodynamics, reduced the expression of TNF-α and IL-6, and suppressed perioperative stress responses (Liu et al., 2019).